News & Perspective

Mar 07, 2006

Mar 07, 2006

HHS using Indonesian strain for second H5N1 flu vaccine

(CIDRAP News) – A second vaccine against human H5N1 influenza is being developed, US Health and Human Services (HHS) Secretary Mike Leavitt announced yesterday.

In a speech at an immunization conference, Leavitt announced that he has authorized the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to start work on a second vaccine, according to an Associated Press (AP) report published yesterday.

Sep 13, 2006

Sep 13, 2006

Live H5N1 vaccines show potential in animal study

(CIDRAP News) – Live-virus vaccines made from a combination of H5N1 avian influenza virus and another flu strain protected laboratory mice and ferrets from deadly infection with several different H5N1 strains, according to a report published yesterday.

Sep 28, 2006

Sep 28, 2006

1918 flu virus triggers extreme immune reaction in mice

(CIDRAP News) – A study in which mice were infected with the resurrected 1918 Spanish influenza virus has yielded fresh evidence for the view that the virus could trigger a suicidal immune response—one that has often been compared with the effects of the H5N1 avian flu virus on susceptible humans.

Oct 13, 2006

Oct 13, 2006

Study supports concept of 2-stage H5N1 vaccination

(CIDRAP News) – The human immune system may respond better to a vaccine for a new strain of H5N1 avian influenza if it is prepared in advance with a vaccine based on an existing H5N1 strain, the preliminary results of a government-sponsored study suggest.

Nov 15, 2006

Nov 15, 2006

'Gene chip' test could speed H5N1 diagnosis

(CIDRAP News) – Scientists say they have developed an inexpensive "gene chip" test that can quickly identify a variety of influenza A viruses, including H5N1, and is less apt to be confused by viral mutations than other tests are.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»